NCT01947140 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 18
- group Id
- BG009
- value
- 47
- units
- Participants
- groups
- description
- Cohort 1, Dose Level -1 Subjects will be administered through IV: Pralatrexate 10 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG000
- title
- Pralatrexate 10 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 2A, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG001
- title
- Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 2B, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG002
- title
- Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 3A, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 14 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG003
- title
- Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2
- description
- Cohort 3B, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 14 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG004
- title
- Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2
- description
- Cohort 4A, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG005
- title
- Phase 1 Schedule A: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 4B, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG006
- title
- Phase 1 Schedule B: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 5B, Dose Level 4 Subjects will be administered through IV: Pralatrexate 25 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG007
- title
- Phase 1 Schedule B: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2
- description
- Subjects will receive Pralatrexate 25 mg/m2 and Romidepsin 12 mg/m2 will be given intravenously once weekly on days 1 and 15 on a 28-day cycle.
- id
- BG008
- title
- Phase 2
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 18
- group Id
- BG009
- value
- 47
- title
- > 18 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 17
- title
- Female
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 12
- group Id
- BG009
- value
- 30
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 35
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 31
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 18
- group Id
- BG009
- value
- 47
- units
- Participants
- groups
- description
- Cohort 1, Dose Level -1 Subjects will be administered through IV: Pralatrexate 10 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG000
- title
- Pralatrexate 10 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 2A, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG001
- title
- Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 2B, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG002
- title
- Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 3A, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 14 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG003
- title
- Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2
- description
- Cohort 3B, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 14 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG004
- title
- Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2
- description
- Cohort 4A, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
- id
- BG005
- title
- Phase 1 Schedule A: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 4B, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG006
- title
- Phase 1 Schedule B: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2
- description
- Cohort 5B, Dose Level 4 Subjects will be administered through IV: Pralatrexate 25 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
- id
- BG007
- title
- Phase 1 Schedule B: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2
- description
- Subjects will receive Pralatrexate 25 mg/m2 and Romidepsin 12 mg/m2 will be given intravenously once weekly on days 1 and 15 on a 28-day cycle.
- id
- BG008
- title
- Phase 2
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 18
- group Id
- BG009
- value
- 47
- title
- > 18 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 17
- title
- Female
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 12
- group Id
- BG009
- value
- 30
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 35
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 31
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-d643ffaf417bcef6d45eb5e0
Preserved source evidence · Not medical advice
Triangle